BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of Baxter International Inc. shareholders who purchased stock between February 23, 2022, and July 30, 2025, alleging that the company misled investors regarding the safety and efficacy of its Novum LVP devices [1][5]. Group 1: Lawsuit Details - The class action lawsuit claims that Baxter failed to disclose systemic defects in the Novum LVP devices, which led to malfunctions and posed serious risks to patients [5]. - Allegations include that Baxter was aware of multiple device malfunctions, injuries, and deaths but did not take adequate remedial measures [5]. - The lawsuit asserts that Baxter's statements about the safety, efficacy, and sales prospects of the Novum LVPs were materially false and misleading [5]. Group 2: Participation Information - Shareholders who purchased Baxter common stock during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - Interested parties can join the class action by visiting the provided link or contacting the law firm directly [3][6].